SCHEMBL6201405

SCHEMBL6201405

COC(=O)c1c[c]ccc1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
CXCR2 P25025 2/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
CFTR P13569 1/20 0.35
EPAS1 Q99814 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
SLC6A3 Q01959 1/20 0.33
HSD11B1 P28845 1/20 0.33
CXCR1 P25024 1/20 0.33
NOTUM Q6P988 1/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SDHB P21912 1/20 0.32
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4442981 0.80 L3MBTL1 (0.61) L3MBTL1LMNATSHRCFTRCA1
SCHEMBL17080255 0.78 KDM4E (0.48) CXCR2EPAS1HSD11B1KMT2AMAPT
SCHEMBL2443988 0.77 GAA (0.45) LMNATSHRCFTRCA1CA2
SCHEMBL8034327 0.77 DRD2 (0.33) CXCR2CA1CA2CXCR1
SCHEMBL5937228 0.76 CYP46A1 (0.43) L3MBTL1LMNATSHRCFTREPAS1
SCHEMBL4634707 0.76 EPAS1 (0.47) L3MBTL1CXCR2LMNACFTREPAS1
SCHEMBL2314446 0.76 NOTUM (0.47) L3MBTL1EPAS1CA1CA2CA9
SCHEMBL4634289 0.76 FFAR4 (0.52) L3MBTL1CFTREPAS1CA1CA2
SCHEMBL15826901 0.75 EPAS1 (0.49) L3MBTL1LMNAEPAS1SLC6A3KMT2A
SCHEMBL7654198 0.75 RAB9A (0.44) L3MBTL1LMNATSHREPAS1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed